Skip to content

Zhoabex Supreme

by Rose Pharma S.A.

Ref ZHOABEX SUPREME

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number764018792ANCLHAER Basic UDI-DI 07640187920338UDI-DIDate9 Oct 2026RegisteredStatusActive EUDAMED: not on the EU market

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
Aliaxin/Nuavis
Model / Reference
ZHOABEX SUPREME
Primary DI / UDI-DI
07640187920338
Basic UDI-DI
764018792ANCLHAER
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
Medical Purpose
ALIAXIN/NUAVIS

Manufacturer details

EUDAMED SRN
CH-PR-000059255

Other devices from Rose Pharma S.A.

See all devices from Rose Pharma S.A. →

Properties

  • Sterile